Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.89
0.03 (3.63%)
At close: May 12, 2025, 3:59 PM
0.89
0.33%
After-hours: May 12, 2025, 06:55 PM EDT
3.63% (1D)
Bid | 0.79 |
Market Cap | 68.78M |
Revenue (ttm) | 1.66M |
Net Income (ttm) | -34.35M |
EPS (ttm) | -0.47 |
PE Ratio (ttm) | -1.89 |
Forward PE | -1.58 |
Analyst | Buy |
Ask | 1 |
Volume | 126,359 |
Avg. Volume (20D) | 190,137 |
Open | 0.88 |
Previous Close | 0.86 |
Day's Range | 0.86 - 0.92 |
52-Week Range | 0.70 - 1.65 |
Beta | 2.11 |
About CLSD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLSD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLSD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Clearside Biomedical Inc. is scheduled to release its earnings on May 14, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+14.82%
Clearside Biomedical shares are trading higher aft...
Unlock content with
Pro Subscription
10 months ago
+15.74%
Clearside Biomedical shares are trading higher after Oppenheimer initiated coverage with an Outperform rating and a price target of $5.